Related Experiment Video
Updated: Apr 18, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Thromboprophylaxis: striking a balance between under-treatment and over-treatment
1Department of Clinical Medicine, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka. Senaka.ucfm@gmail.com.
Abstract:
Venous thromboembolism (VTE) is an important cause of morbidity and mortality among patients admitted to hospital. Pulmonary embolism results in 5-10% of deaths, and is the commonest cause of preventable deaths in hospitalised patients. In addition, considerable morbidity results from VTE, such as post-thrombotic syndrome and chronic thromboembolic pulmonary hypertension. The economic burden resulting from VTE and its complications is high.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Therapeutic Index

